Shuanghu T. Yuan
17 Lujiang Road
Hefei, 230001, China
Hefei, 230001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 148 publications
Dual-targeting macrophage membrane nanosystem enhances radiotherapy-induced antitumor immunity via synergistic nuclear and mitochondrial DNA damage.
Journal: Biomaterials science
Published: June 16, 2026
Retraction: MicroRNA98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Journal: Oncotarget
Published: May 26, 2026
Tertiary Lymphoid Structures Predict Efficacy of Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma.
Journal: Annals of clinical and laboratory science
Published: April 02, 2026
KDM4D enhances radiosensitivity in esophageal squamous cell carcinoma through the SRBD1/RPL11/c-Myc/WIP1/CHK1 axis.
Journal: American journal of translational research
Published: February 05, 2026
Calcium overload induces reactive oxygen species to enhance glioblastoma radiosensitivity.
Journal: Medical gas research
Published: January 30, 2026
The Impact of Tumor Volume Change Rate During Neoadjuvant Chemoradiotherapy-immunotherapy and of the Timing to Surgery on Prognosis in Patients with Esophageal Squamous Cell Carcinoma: A Multicenter Study.
Journal: Journal of gastrointestinal cancer
Published: January 26, 2026
Ionomycin enhances radiosensitivity in breast cancer through reactive oxygen species generation and mitochondrial permeability transition pore opening.
Journal: Medical gas research
Published: January 22, 2026
Impact of radiation dose to immune cells on survival in patients with extensive-stage small cell lung cancer receiving consolidative thoracic radiotherapy after chemoimmunotherapy.
Journal: Future oncology (London, England)
Published: December 30, 2025
Engineering bacterial outer membrane vesicles synergetically boost superactivated anti-tumor immunity induced by radiotherapy via sustained DNA damage.
Journal: Biomaterials advances
Published: December 20, 2025
Radiotherapy synergizes with CD24 blockade to initiate macrophage-driven systemic antitumor immunity in non-small cell lung cancer.
Journal: Experimental hematology & oncology
Published: December 12, 2025
Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III EGFR-mutated NSCLC: LAURA China cohort.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 04, 2025
Last Updated: 09/26/2026